NS-10712

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNS-10712
Drug Alias NameNS-10712
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuronal acetylcholine receptor subunit alpha-6 agonists
TargetsNeuronal acetylcholine receptor subunit alpha-6
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDanPET AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDanPET AB
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A